In this prospective study of maternal serum estrogen metabolites and ER-/PR- breast cancer risk up to two decades after pregnancy, we found largely positive associations that remained after adjustment for total E2 and when analyses were restricted to fewer years since last pregnancy. The gene discussed is ESR1; the disease is breast cancer.